Dipeptidyl peptidase

Results: 124



#Item
71DEPARTMENT OF DEFENSE PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS February 2012 I. 	 CONVENING The Department of Defense (DoD) Pharmacy and Therapeutics (P&T) Committee convened at 0800 hours on February 16 and 1

DEPARTMENT OF DEFENSE PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS February 2012 I. CONVENING The Department of Defense (DoD) Pharmacy and Therapeutics (P&T) Committee convened at 0800 hours on February 16 and 1

Add to Reading List

Source URL: www.tricare.mil

Language: English - Date: 2012-06-04 17:17:09
72B.C. PharmaCare is a government-funded drug plan. It helps British Columbians with the cost of eligible prescription drugs and specific medical supplies. About PharmaCare

B.C. PharmaCare is a government-funded drug plan. It helps British Columbians with the cost of eligible prescription drugs and specific medical supplies. About PharmaCare

Add to Reading List

Source URL: www.health.gov.bc.ca

Language: English - Date: 2014-08-01 13:22:57
73Kansas Medical Assistance Program  P O Box 3571 Topeka, KS[removed]Provider[removed]Beneficiary[removed]

Kansas Medical Assistance Program P O Box 3571 Topeka, KS[removed]Provider[removed]Beneficiary[removed]

Add to Reading List

Source URL: www.kdheks.gov

Language: English - Date: 2014-08-01 10:00:11
74Information for Health Care Professionals  Transitioning Patients to a Different Dipeptidyl Peptidase-4 (DPP-4) Inhibitor Background Ten classes of antihyperglycemic medications are currently approved for use in type 2 d

Information for Health Care Professionals Transitioning Patients to a Different Dipeptidyl Peptidase-4 (DPP-4) Inhibitor Background Ten classes of antihyperglycemic medications are currently approved for use in type 2 d

Add to Reading List

Source URL: www.health.gov.bc.ca

Language: English - Date: 2014-10-06 15:16:38
75Drug Safety Communication for Saxagliptin

Drug Safety Communication for Saxagliptin

Add to Reading List

Source URL: www.fda.gov

Language: English
76Continuing Education Discussion Guide  A Guide to Emerging Treatments for Type 2 Diabetes: Focus on Incretin Therapies This continuing education discussion guide is part of an educational initiative designed to provide

Continuing Education Discussion Guide A Guide to Emerging Treatments for Type 2 Diabetes: Focus on Incretin Therapies This continuing education discussion guide is part of an educational initiative designed to provide

Add to Reading List

Source URL: www.ashpadvantagemedia.com

Language: English - Date: 2014-02-04 15:23:23
77DIVISION OF BIOEQUIVALENCE REVIEW

DIVISION OF BIOEQUIVALENCE REVIEW

Add to Reading List

Source URL: www.fda.gov

Language: English
78DIVISION OF BIOEQUIVALENCE REVIEW

DIVISION OF BIOEQUIVALENCE REVIEW

Add to Reading List

Source URL: www.fda.gov

Language: English
79COMMONWEALTH of VIRGINIA Department of Medical Assistance Services DRUG UTILIZATION REVIEW PROGRAM Virginia Medicaid Drug Utilization Review (DUR) Board Quarterly Meeting

COMMONWEALTH of VIRGINIA Department of Medical Assistance Services DRUG UTILIZATION REVIEW PROGRAM Virginia Medicaid Drug Utilization Review (DUR) Board Quarterly Meeting

Add to Reading List

Source URL: www.dmas.virginia.gov

Language: English - Date: 2013-03-18 06:50:59
80Nancy A. Thornberry Nancy A. Thornberry is Senior Vice President and Franchise Head, Diabetes and Obesity, for Merck & Co. Inc. In this role, she leads discovery and clinical research in metabolic disorders such as diabe

Nancy A. Thornberry Nancy A. Thornberry is Senior Vice President and Franchise Head, Diabetes and Obesity, for Merck & Co. Inc. In this role, she leads discovery and clinical research in metabolic disorders such as diabe

Add to Reading List

Source URL: www2.kenes.com

Language: English - Date: 2010-05-11 04:44:04